Analysts Suggest There’s Still Momentum for Helen of Troy Limited (HELE), Radius Health, Inc. (RDUS)

Helen of Troy Limited (NASDAQ:HELE) recent rally took place on significantly less volume which dipped to nearly 654948 contracts on 10-Jan-19 versus its daily average of 722500. The first sale was made at $110.9 but later the stock became weaker, and closed with a gain of 2.11%. It was last traded at $114.24 apiece.

Helen of Troy Limited (HELE): Buy Candidate With 28.33% Upside Potential

Helen of Troy Limited is maintained at an average buy rating by 5 stock analysts, and there are at least 2.72% of shares outstanding that are currently legally short sold. The shares went down by -16.69% in value last month. Year-to-date it plunged -12.91%. Analysts are turning out to be more optimistic than before, with 5 of analysts who cover Helen of Troy Limited (NASDAQ:HELE) advice adding it to buy candidate list. Wall Street experts also assign a $146.6 price target on Helen of Troy Limited, pointing towards a 28.33% rally from current levels. The stock is trading for about -21.47% less than its 52-week high.

Helen of Troy Limited Reports -1.55% Sales Growth

Revenue scored -1.55% growth from the previous quarter, coming up with $349.19 million.

HELE Retreats -10.98% In A Week

This company shares (HELE) so far managed to recover 40.86% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 5.31% while shortening the period to a week, volatility was 3.83%. The share price has yet to cross its 20 days moving average, floating at a distance of -12.99% and sits -14.54% lower versus its 50 days moving average. When looking at the past five sessions, the stock returned -10.98% losses and is up by 1.04% compared with its 200-day moving average of $123.58. Also, Helen of Troy Limited (HELE) needs to expand a 19.19% increase it experienced over the past twelve months.

Radius Health, Inc. (NASDAQ:RDUS) Consensus Call At 0

As regular trading ended, Radius Health, Inc. (RDUS) stock brought in a $0.35 rise to $16.94. The day started at a price of $16.46 but then traded as high as $16.98 before giving part of the gains back. As for this week, analysts appear content to stick with their bright outlook with the consensus call at 0. Radius Health, Inc. is given 2 buy-equivalent recommendations, 0 sells and 4 holds. The company shares sank -58.84% from their peak of $41.16 and now has a $784.83 million market value of equity.

Radius Health, Inc. Could Grow 116.71% More

RDUS’s mean recommendation on Reuter’s scale presents no change from 2.25 thirty days ago to 2.25 now, which indicates a hold consensus from the analyst community. They see Radius Health, Inc. (RDUS) price hitting a mean target of $36.71 a share, meaning the stock still has potential that could lift the price another 116.71% . Also, the recent close suggests the stock is underpriced by 206.97% compared to the most bullish target.

Radius Health, Inc. (RDUS) Returns 2.73% This Year

The company had seen its current volume reaching at 663259 shares in the last trade. That compares with the recent volume average of 759180. At the close of regular trading, its last week’s stock price volatility was 7.05% which for the month reaches 5.81%. Radius Health, Inc. dipped to as low as $16.11 throughout the day and has returned 2.73% in this year. At one point in the past year, the shares traded as low as $12.81 but has recovered 32.24% since then.